Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of Patients With Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.

NCT07207239 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.

NCT NCT07207239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07207239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of Patients With Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.
Lead sponsor
Semmelweis University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
June 13, 2025
Completion date
June 13, 2028
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression - major depressive disorder, transcranial magnetic stimulation, repetitive